Organon France Revenue and Competitors

Paris, France

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Organon France's estimated annual revenue is currently $29.9M per year.(i)
  • Organon France's estimated revenue per employee is $201,000

Employee Data

  • Organon France has 149 Employees.(i)
  • Organon France grew their employee count by 1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$45.6M2270%N/AN/A
#2
$19.3M965%N/AN/A
#3
$36.2M1805%N/AN/A
#4
$34M16933%N/AN/A
#5
$173.7M86420%N/AN/A
#6
$45M2242%N/AN/A
#7
$48.2M2406%N/AN/A
#8
$22.1M1108%N/AN/A
#9
$22.1M110-13%N/AN/A
#10
$27.5M1371%N/AN/A
Add Company

What Is Organon France?

Laboratoire pharmaceutique international, leader en santé des femmes et acteur majeur dans la mise à disposition de médicaments biosimilaires et de médicaments historiques à forts enjeux de santé publique. Pour plus d'informations, rendez-vous sur www.organon.fr ou suivez-nous sur https://twitter.com/OrganonFrance Pour contacter notre service d’information médicale : ☎️ 01 57 77 32 00 ???? info.medicale.fr@organon.com

keywords:N/A

N/A

Total Funding

149

Number of Employees

$29.9M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Organon France News

2022-04-19 - Posaconazole Market Ever-Growing Demanding ...

Patheon, Organon International, BrightGene Bio-Medical Technology, Yabang, ... Europe [Germany, UK, France, Italy, Rest of Europe]

2022-04-17 - All-Star Speaker Lineup for Medical Affairs Professional Society (MAPS) 2022 EMEA Annual Meeting

MAPS France/Benelux Chapter Lead Chief Medical Officer, Organon Lori Mouser: Field Medical Co-Chair MAPS Field Medical FAWG Member

2022-04-17 - Equities Research Analysts' Downgrades for April 21st (AA ...

... Jersey, Germany, France, Finland, Norway, Sweden, the Netherlands, Spain, ... According to Zacks, “Organon is a healthcare company.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.8M1499%N/A
#2
$36.1M1496%N/A
#3
$23.8M149-1%N/A
#4
N/A14939%N/A
#5
$16.7M1491%N/A